Skip to main content
Top
Published in: Clinical Rheumatology 8/2019

01-08-2019 | Rheumatoid Arthritis | Original Article

Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies

Authors: Xiao-juan Qiu, Xiu-ling Zhang, Lai-sheng Cai, Chen Yan, Le Yu, Jie Fan, Rong-wei Zhang, Jing-wei Huang, Xin-wang Duan

Published in: Clinical Rheumatology | Issue 8/2019

Login to get access

Abstract

Objectives

Rheumatoid arthritis (RA) may increase the risk of anxiety, but results from prior studies have no consensus. Our study aimed to evaluate the relationship between RA and incident anxiety by using a quantitative meta-analysis.

Methods

A number of databases were used to gather relevant information; they included PubMed, EMBASE, and Web of Science, with the publication date of articles limited up to July 23, 2018. To evaluate their association, an odds ratio (OR) with 95% confidence interval (CI) was used. The random-effects model played a crucial role in calculating the pooled odds ratio, while subgroup analyses and sensitivity analyses were also performed.

Results

A total of 10 studies, including 6201 cases of anxiety and 139,875 participants, met our inclusion criteria for this meta-analysis. All individuals were without anxiety at baseline. The follow-up period ranged from 1.0 to 9.2 years. Overall, the quantitative meta-analysis suggested that subjects with RA were associated with a significantly increased risk of anxiety incidence (OR, 1.20; 95% CI, 1.03–1.39) than those without.

Conclusion

Results of this meta-analysis indicate that individuals with RA may confer an increased risk for the development of anxiety. Future studies should explore whether clinical manifestations of RA are modifiable risk factors for anxiety.
Literature
1.
go back to reference Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRefPubMed Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRefPubMed
2.
3.
go back to reference Watad A, Agmon-Levin N, Gilburd B, Lidar M, Amital H, Shoenfeld Y (2014) Predictive value of anti-citrullinated peptide antibodies: a real life experience. Immunol Res 60:348–355CrossRefPubMed Watad A, Agmon-Levin N, Gilburd B, Lidar M, Amital H, Shoenfeld Y (2014) Predictive value of anti-citrullinated peptide antibodies: a real life experience. Immunol Res 60:348–355CrossRefPubMed
5.
go back to reference Sharpe L, Sensky T, Allard S (2001) The course of depression in recent onset rheumatoid arthritis: the predictive role of disability, illness perceptions, pain and coping. J Psychosom Res 51:713–719CrossRefPubMed Sharpe L, Sensky T, Allard S (2001) The course of depression in recent onset rheumatoid arthritis: the predictive role of disability, illness perceptions, pain and coping. J Psychosom Res 51:713–719CrossRefPubMed
6.
go back to reference VanDyke MM, Parker JC, Smarr KL, Hewett JE, Johnson GE, Slaughter JR et al (2004) Anxiety in rheumatoid arthritis. Arthritis Rheum 51:408–412CrossRefPubMed VanDyke MM, Parker JC, Smarr KL, Hewett JE, Johnson GE, Slaughter JR et al (2004) Anxiety in rheumatoid arthritis. Arthritis Rheum 51:408–412CrossRefPubMed
7.
go back to reference Chandarana PC, Eals M, Steingart AB, Bellamy N, Allen S (1987) The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatr 32:356–361CrossRef Chandarana PC, Eals M, Steingart AB, Bellamy N, Allen S (1987) The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatr 32:356–361CrossRef
8.
go back to reference Ho RC, Fu EH, Chua AN, Cheak AA, Mak A (2011) Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis 14:37–47CrossRefPubMed Ho RC, Fu EH, Chua AN, Cheak AA, Mak A (2011) Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis. Int J Rheum Dis 14:37–47CrossRefPubMed
9.
go back to reference Imran MY, Khan SEA, Ahmad NM, Raja SF, Saeed MA, Haider II (2015) Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci 31:393–397CrossRefPubMedPubMedCentral Imran MY, Khan SEA, Ahmad NM, Raja SF, Saeed MA, Haider II (2015) Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci 31:393–397CrossRefPubMedPubMedCentral
10.
go back to reference Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N (2009) Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 61:1018–1024CrossRefPubMed Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N (2009) Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 61:1018–1024CrossRefPubMed
11.
go back to reference Matcham F, Norton S, Scott DL, Steer S, Hotopf M (2016) Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford) 55:268–278CrossRef Matcham F, Norton S, Scott DL, Steer S, Hotopf M (2016) Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford) 55:268–278CrossRef
12.
go back to reference Radanov BP, Schwarz HA, Frost SA, Augustiny KF (1997) Relationship between self-rated functional status and psychosocial stress in patients suffering from rheumatoid arthritis. Psychother Psychosom 66:252–257CrossRefPubMed Radanov BP, Schwarz HA, Frost SA, Augustiny KF (1997) Relationship between self-rated functional status and psychosocial stress in patients suffering from rheumatoid arthritis. Psychother Psychosom 66:252–257CrossRefPubMed
13.
go back to reference Li M, Fan YL, Tang ZY, Cheng XS (2014) Schizophrenia and risk of stroke: a meta-analysis of cohort studies. Int J Cardiol 173:588–590CrossRefPubMed Li M, Fan YL, Tang ZY, Cheng XS (2014) Schizophrenia and risk of stroke: a meta-analysis of cohort studies. Int J Cardiol 173:588–590CrossRefPubMed
14.
go back to reference Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:2136–2148CrossRef Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:2136–2148CrossRef
15.
go back to reference Li M, Li K, Zhang XW, Hou WS, Tang ZY (2015) Habitual snoring and risk of stroke: a meta-analysis of prospective studies. Int J Cardiol 185:46–49CrossRefPubMed Li M, Li K, Zhang XW, Hou WS, Tang ZY (2015) Habitual snoring and risk of stroke: a meta-analysis of prospective studies. Int J Cardiol 185:46–49CrossRefPubMed
16.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341CrossRefPubMed
17.
go back to reference Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
18.
go back to reference Li M, Hou W, Zhang X, Hu L, Tang Z (2014) Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis 232:265–270CrossRefPubMed Li M, Hou W, Zhang X, Hu L, Tang Z (2014) Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis 232:265–270CrossRefPubMed
19.
20.
go back to reference Gafvels C, Hagerstrom M, Rane K, Wajngot A, Wandell PE (2016) Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis. Health Psychol Open 3:2055102916678107CrossRefPubMedPubMedCentral Gafvels C, Hagerstrom M, Rane K, Wajngot A, Wandell PE (2016) Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis. Health Psychol Open 3:2055102916678107CrossRefPubMedPubMedCentral
21.
go back to reference Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872–878CrossRefPubMed Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872–878CrossRefPubMed
22.
go back to reference Jamshidi AR, Banihashemi AT, Paragomi P, Hasanzadeh M, Barghamdi M, Ghoroghi S (2016) Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population. Rheumatol Int 36:1119–1125CrossRefPubMed Jamshidi AR, Banihashemi AT, Paragomi P, Hasanzadeh M, Barghamdi M, Ghoroghi S (2016) Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population. Rheumatol Int 36:1119–1125CrossRefPubMed
23.
go back to reference Kronisch C, McLernon DJ, Dale J, Paterson C, Ralston SH, Reid DM et al (2016) Predicting functional disability: one-year results from the Scottish early rheumatoid arthritis inception cohort. Arthritis Rheum 68:1596–1602CrossRef Kronisch C, McLernon DJ, Dale J, Paterson C, Ralston SH, Reid DM et al (2016) Predicting functional disability: one-year results from the Scottish early rheumatoid arthritis inception cohort. Arthritis Rheum 68:1596–1602CrossRef
24.
go back to reference Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, el-Gabalawy R, Katz A, Fisk JD, Bernstein CN, for the Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease (2018) Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res 70:970–978CrossRef Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, el-Gabalawy R, Katz A, Fisk JD, Bernstein CN, for the Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease (2018) Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res 70:970–978CrossRef
25.
go back to reference Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, He L (2018) Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin Rheumatol 37:179–184CrossRefPubMed Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, He L (2018) Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin Rheumatol 37:179–184CrossRefPubMed
26.
go back to reference van’t Land H, Verdurmen J, ten Have M, van Dorsselaer S, Beekman A, de Graaf R (2010) The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res 68:187–193CrossRef van’t Land H, Verdurmen J, ten Have M, van Dorsselaer S, Beekman A, de Graaf R (2010) The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res 68:187–193CrossRef
27.
go back to reference Verstappen SMM, Jacobs JWG, Huisman A-M, van Rijthoven AWAM, Sokka T, Bijlsma JWJ (2007) Functional health assessment questionnaire (HAQ) and psychological HAQ are associated with and predicted by different factors in rheumatoid arthritis. J Rheumatol 34:1837–1840PubMed Verstappen SMM, Jacobs JWG, Huisman A-M, van Rijthoven AWAM, Sokka T, Bijlsma JWJ (2007) Functional health assessment questionnaire (HAQ) and psychological HAQ are associated with and predicted by different factors in rheumatoid arthritis. J Rheumatol 34:1837–1840PubMed
28.
go back to reference Watad A, Bragazzi NL, Adawi M, Aljadeff G, Amital H, Comaneshter D, Cohen AD, Amital D (2017) Anxiety disorder among rheumatoid arthritis patients: insights from real-life data. J Affect Disord 213:30–34CrossRefPubMed Watad A, Bragazzi NL, Adawi M, Aljadeff G, Amital H, Comaneshter D, Cohen AD, Amital D (2017) Anxiety disorder among rheumatoid arthritis patients: insights from real-life data. J Affect Disord 213:30–34CrossRefPubMed
29.
go back to reference Zhang L, Xia Y, Zhang Q, Fu T, Yin R, Guo G, Li L, Gu Z (2017) The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis. Psychol Health Med 22:28–36CrossRefPubMed Zhang L, Xia Y, Zhang Q, Fu T, Yin R, Guo G, Li L, Gu Z (2017) The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis. Psychol Health Med 22:28–36CrossRefPubMed
30.
go back to reference Sheehy C, Murphy E, Barry M (2006) Depression in rheumatoid arthritis--underscoring the problem. Rheumatology (Oxford) 45:1325–1327CrossRef Sheehy C, Murphy E, Barry M (2006) Depression in rheumatoid arthritis--underscoring the problem. Rheumatology (Oxford) 45:1325–1327CrossRef
31.
go back to reference Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A (2011) Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) 50:401–409CrossRef Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A (2011) Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) 50:401–409CrossRef
32.
go back to reference Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752CrossRefPubMed Joyce AT, Smith P, Khandker R, Melin JM, Singh A (2009) Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 36:743–752CrossRefPubMed
33.
go back to reference Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019PubMed Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019PubMed
34.
go back to reference Pollard L, Choy EH, Scott DL (2005) The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 23:S43–S52PubMed Pollard L, Choy EH, Scott DL (2005) The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 23:S43–S52PubMed
35.
go back to reference McFarlane AC, Brooks PM (1988) An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol 15:926–931PubMed McFarlane AC, Brooks PM (1988) An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol 15:926–931PubMed
36.
go back to reference Cordingley L, Prajapati R, Plant D, Maskell D, Morgan C, Ali FR, Morgan AW, Wilson AG, Isaacs JD, the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Barton A (2014) Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. Arthritis Care Res 66:861–868CrossRef Cordingley L, Prajapati R, Plant D, Maskell D, Morgan C, Ali FR, Morgan AW, Wilson AG, Isaacs JD, the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Barton A (2014) Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. Arthritis Care Res 66:861–868CrossRef
37.
go back to reference El-Miedany YM, El-Rasheed AH (2002) Is anxiety a more common disorder than depression in rheumatoid arthritis? Joint Bone Spine 69:300–306CrossRefPubMed El-Miedany YM, El-Rasheed AH (2002) Is anxiety a more common disorder than depression in rheumatoid arthritis? Joint Bone Spine 69:300–306CrossRefPubMed
38.
go back to reference Zautra AJ, Davis MC, Reich JW, Nicassario P, Tennen H, Finan P, Kratz A, Parrish B, Irwin MR (2008) Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 76:408–421CrossRefPubMed Zautra AJ, Davis MC, Reich JW, Nicassario P, Tennen H, Finan P, Kratz A, Parrish B, Irwin MR (2008) Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 76:408–421CrossRefPubMed
39.
go back to reference El-Tantawy AM, El-Sayed AE, Kora BA, Amin RT (2008) Psychiatric morbidity associated with some cytokines (IL-1beta, IL-12, IL-18 and TNF-alpha) among rheumatoid arthritis patients. Egypt J Immunol 15:1–11PubMed El-Tantawy AM, El-Sayed AE, Kora BA, Amin RT (2008) Psychiatric morbidity associated with some cytokines (IL-1beta, IL-12, IL-18 and TNF-alpha) among rheumatoid arthritis patients. Egypt J Immunol 15:1–11PubMed
40.
go back to reference Liu Y, Ho RC, Mak A (2012) The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis 15:183–187CrossRefPubMed Liu Y, Ho RC, Mak A (2012) The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis 15:183–187CrossRefPubMed
41.
go back to reference Delisi LE, King AC, Targum S (1984) Serum immunoglobulin concentrations in patients admitted to an acute psychiatric inpatient service. Br J Psychiatry 145:661–665CrossRefPubMed Delisi LE, King AC, Targum S (1984) Serum immunoglobulin concentrations in patients admitted to an acute psychiatric inpatient service. Br J Psychiatry 145:661–665CrossRefPubMed
42.
go back to reference Ahokas A (1986) Immunoglobulin and C3 abnormalities in acute psychiatric disorders. Acta Psychiatr Scand 74:542–547CrossRefPubMed Ahokas A (1986) Immunoglobulin and C3 abnormalities in acute psychiatric disorders. Acta Psychiatr Scand 74:542–547CrossRefPubMed
43.
go back to reference Klein JF (1992) Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician 46:1469–1474PubMed Klein JF (1992) Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician 46:1469–1474PubMed
44.
go back to reference Jacobs JW, Geenen R, Evers AW, van Jaarsveld CH, Kraaimaat FW, Bijlsma JW (2001) Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis. Ann Rheum Dis 60:61–64CrossRefPubMedPubMedCentral Jacobs JW, Geenen R, Evers AW, van Jaarsveld CH, Kraaimaat FW, Bijlsma JW (2001) Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis. Ann Rheum Dis 60:61–64CrossRefPubMedPubMedCentral
45.
go back to reference Jiang HK, Chang DM (1999) Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin Rheumatol 18:339–345CrossRefPubMed Jiang HK, Chang DM (1999) Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin Rheumatol 18:339–345CrossRefPubMed
46.
go back to reference Shah JN, Qureshi SU, Jawaid A, Schulz PE (2012) Is there evidence for late cognitive decline in chronic schizophrenia? Psychiatr Q 83:127–144CrossRefPubMed Shah JN, Qureshi SU, Jawaid A, Schulz PE (2012) Is there evidence for late cognitive decline in chronic schizophrenia? Psychiatr Q 83:127–144CrossRefPubMed
47.
go back to reference Bacconnier L, Rincheval N, Flipo RM, Goupille P, Daures JP, Boulenger JP et al (2015) Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort. Rheumatology (Oxford) 54:520–527CrossRef Bacconnier L, Rincheval N, Flipo RM, Goupille P, Daures JP, Boulenger JP et al (2015) Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort. Rheumatology (Oxford) 54:520–527CrossRef
48.
go back to reference Axford J, Heron C, Ross F, Victor CR (2008) Management of knee osteoarthritis in primary care: pain and depression are the major obstacles. J Psychosom Res 64:461–467CrossRefPubMed Axford J, Heron C, Ross F, Victor CR (2008) Management of knee osteoarthritis in primary care: pain and depression are the major obstacles. J Psychosom Res 64:461–467CrossRefPubMed
49.
go back to reference Kekow J, Moots RJ, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R (2010) Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis 69:222–225CrossRefPubMed Kekow J, Moots RJ, Emery P, Durez P, Koenig A, Singh A, Pedersen R, Robertson D, Freundlich B, Sato R (2010) Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis 69:222–225CrossRefPubMed
Metadata
Title
Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies
Authors
Xiao-juan Qiu
Xiu-ling Zhang
Lai-sheng Cai
Chen Yan
Le Yu
Jie Fan
Rong-wei Zhang
Jing-wei Huang
Xin-wang Duan
Publication date
01-08-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04502-8

Other articles of this Issue 8/2019

Clinical Rheumatology 8/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.